Ascorbic Acid (Vitamin C) is seemingly so ubiquitous an intervention in integrative healthcare it is easy to overlook its potential therapeutic benefit as well as economical cost profile when considering therapies. One therapeutic target that is both common and also often filled with costly interventions is cardiovascular prevention and disease. All the common natural interventions are necessary and generally worth the cost. This paper and the other noted below reminded me personally of the profound benefit vitamin C can add to cardiovascular prevention and therapy.
- Reviewed paper: Valls N, et al. Amelioration of persistent left ventricular function impairment through increased plasma ascorbate levels following myocardial infarction. Redox Rep. 2016. PMID 26066587
- See “ReDox Biology” – ConsultDrA.com – Free Clinical Discussion and Research Review – “ReDox” –Our ever evolving understanding of oxidative balance, kinetics and implications in health and disease.
- Secor D, et al. Ascorbate inhibits platelet-endothelial adhesion in an in-vitro model of sepsis via reduced endothelial surface P-selectin expression. Blood Coagul Fibrinolysis. 2016. PMID 26829365